Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 24-May-22 5:15 PM View:  | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-22 | Grant | 10,917 | $0.68 | $7,437.75 | 36% 30.32K to 41.24K | |
| 23-Nov-21 6:54 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-Nov-21 | Grant | 2,559 | $2.01 | $5,143.59 | 9% 27.76K to 30.32K | |
| 14-Jul-21 7:06 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 12-Jul-21 | Grant | 4,519 | $1.74 | $7,863.06 | 19% 23.24K to 27.76K | |
| 24-May-21 6:09 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-May-21 | Grant | 5,257 | $2.80 | $14,719.60 | 29% 17.98K to 23.24K | |
| 23-Nov-20 6:36 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 20-Nov-20 | Grant | 4,832 | $3.00 | $14,496.00 | 37% 13.15K to 17.98K | |
| 05-Oct-20 9:08 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 01-Oct-20 | Option Exercise | 5,423 | $1.15 | $6,236.45 | 70% 7.73K to 13.15K | |
| 05-Oct-20 9:08 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 27-Feb-20 | Option Exercise | 5,423 | $1.15 | $6,236.45 | 235% 2.31K to 7.73K | |
| 24-Oct-18 4:15 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 22-Oct-18 | Conversion | 2,306 | -- | -- | 100% 0 to 2.31K |